The Walgreens Boots Alliance, Inc. (WBA) Shares Bought by State of Wisconsin Investment Board

The Walgreens Boots Alliance, Inc. (WBA) Shares Bought by State of Wisconsin Investment Board

State of Wisconsin Investment Board increased its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 2.4% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 1,114,107 shares of the pharmacy operator’s stock after buying an additional 25,800 shares during the period. State of Wisconsin Investment Board’s holdings in Walgreens Boots Alliance were worth $89,819,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in WBA. Banced Corp boosted its stake in shares of Walgreens Boots Alliance by 3.3% in the second quarter. Banced Corp now owns 6,220 shares of the pharmacy operator’s stock valued at $517,000 after buying an additional 200 shares in the last quarter. Old Mutual Global Investors UK Ltd. boosted its stake in shares of Walgreens Boots Alliance by 628.4% in the second quarter. Old Mutual Global Investors UK Ltd. now owns 74,432 shares of the pharmacy operator’s stock valued at $6,197,000 after buying an additional 64,213 shares in the last quarter. Robeco Institutional Asset Management B.V. boosted its stake in shares of Walgreens Boots Alliance by 165.8% in the second quarter. Robeco Institutional Asset Management B.V. now owns 105,504 shares of the pharmacy operator’s stock valued at $8,825,000 after buying an additional 65,809 shares in the last quarter. MSI Financial Services Inc boosted its stake in shares of Walgreens Boots Alliance by 9.3% in the second quarter. MSI Financial Services Inc now owns 21,280 shares of the pharmacy operator’s stock valued at $1,772,000 after buying an additional 1,810 shares in the last quarter. Finally, JFS Wealth Advisors LLC boosted its stake in shares of Walgreens Boots Alliance by 4.8% in the second quarter. JFS Wealth Advisors LLC now owns 25,222 shares of the pharmacy operator’s stock valued at $2,100,000 after buying an additional 1,151 shares in the last quarter. Hedge funds and other institutional investors own 59.04% of the company’s stock.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at 84.12 on Thursday. The stock has a market capitalization of $90.80 billion, a price-to-earnings ratio of 22.26 and a beta of 1.18. Walgreens Boots Alliance, Inc. has a 1-year low of $71.50 and a 1-year high of $88.00. The company has a 50-day moving average of $84.55 and a 200-day moving average of $82.21.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, January 5th. The pharmacy operator reported $1.10 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.09 by $0.01. Walgreens Boots Alliance had a return on equity of 16.76% and a net margin of 3.52%. The firm earned $28.50 billion during the quarter. During the same period in the prior year, the company posted $1.03 earnings per share. The firm’s revenue for the quarter was down 1.8% compared to the same quarter last year. On average, equities research analysts expect that Walgreens Boots Alliance, Inc. will post $5.00 EPS for the current fiscal year.

WBA has been the topic of several research reports. Jefferies Group upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and boosted their price target for the stock from $87.00 to $95.00 in a research report on Monday, October 17th. Zacks Investment Research cut shares of Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research report on Thursday, October 6th. Deutsche Bank AG restated a “buy” rating and issued a $94.00 price target on shares of Walgreens Boots Alliance in a research report on Wednesday, September 28th. Credit Suisse Group AG restated an “outperform” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a research report on Friday, October 21st. Finally, Wells Fargo & Company initiated coverage on shares of Walgreens Boots Alliance in a research report on Monday, October 31st. They issued an “outperform” rating on the stock. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and thirteen have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $90.59.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,067 shares of the firm’s stock in a transaction on Wednesday, November 2nd. The stock was sold at an average price of $81.30, for a total value of $168,047.10. Following the completion of the sale, the director now directly owns 24,623 shares of the company’s stock, valued at approximately $2,001,849.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Stefano Pessina bought 2,000,000 shares of the business’s stock in a transaction on Friday, November 4th. The stock was bought at an average cost of $81.41 per share, with a total value of $162,820,000.00. The disclosure for this purchase can be found here. 13.50% of the stock is owned by corporate insiders.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Related posts

Leave a Comment